INCYTE CORP 4

EVP & Chief Scientific Officer Patrick A. Mayes had 350 Incyte Corp common shares withheld for taxes in connection with RSU settlement.

On July 2, 2026, Patrick A. Mayes, EVP & Chief Scientific Officer of Incyte Corp, had 350 shares of common stock withheld by the company at an implied price of approximately $116.86 per share, solely to satisfy tax withholding obligations upon the settlement of previously granted restricted stock units. This Form 4 reflects a non-discretionary, administrative transaction rather than an open-market trade, leaving him with direct ownership of 59,661 shares of common stock, which includes 58,730 shares underlying unvested restricted stock units as part of his ongoing equity compensation.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0002079962-26-000007

Alert Tier

4